Home › Free Stock Grades › SRRK
Scholar Rock Holding Corporation (SRRK) Stock Grade
SRRK · Healthcare
C
Market Cap
$5.9B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Scholar Rock Holding Corporation's fundamentals
Scholar Rock Holding Corporation is a biotechnology company with a market capitalization of $7.1 billion that is currently unprofitable, having reported a net loss in its latest annual statement with a net margin of 0.0%. The company showed no year-over-year revenue growth, indicating flat sales performance in its most recent period. As a development-stage biotech firm, Scholar Rock does not pay a dividend and cannot be evaluated using standard profitability metrics like P/E ratio or return on equity.